Neuroscience

Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3401 Etifoxine hydrochlorideTarget: GABAA receptorSummary: GABAA receptor potentiator -
A3416 FK 3311Summary: Selective COX-2 inhibitor -
A3423 Galanthamine2 CitationTarget: AChESummary: Acetylcholinesterase inhibitor -
A3680 OlcegepantTarget: CGRP receptorsSummary: Non-peptide receptor of CGRP,first potent and selective -
A3744 QuetiapineTarget: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptorSummary: Dopamine receptor antagonist -
A2960 LoratadineTarget: Histamine H1 ReceptorsSummary: Peripheral HH1R antagonist -
A2098 PRX-08066 Maleic acidSummary: 5-HT2B receptor antagonist,potent and selective -
B5473 GSK 264220ASummary: endothelial lipase and lipoprotein lipase inhibitor -
A1004 Amyloid Precursor C-Terminal PeptideSummary: For beta amyloid generation -
C4100 Pirinixic Acid AminothiazoleSummary: dual inhibitor of mPGES-1 and 5-LO
